Search results

24 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
McCoy awarded postdoctoral fellowship from Autism Science Foundation
Grants from ASF fund grants student/mentor teams conducting research in autism interventions, early diagnosis, biomarkers, and animal models.
Located in News
Roberts first-author paper in Neuron featured in Faculty of 1000
Philpot lab postdoctoral fellow Adam Roberts' first author publication featured in faculty of 1000
Located in News / 2009 news archives
Philpot and Snider awarded $2 million to study roots of cognitive disabilities
April 2012 -Philpot and Snider will study the cognitive disabilities in patients with RAS/MARK syndromes.
Located in News
August 2013 - Findings published in the journal Nature outline the effects that key enzymes called topoisomerases can have on the genetic machinery behind brain development.
Located in News
Philpot lab members write commentary for Simons Foundation Autism Research Initiative (SFARI) explaining connections between autism, Angelman syndrome and the UBE3A gene
July 2011 - Ben Philpot and postdoctoral fellows Angela Mabb and Matthew Judson write commentary for the Simons Foundation Autism Research Initiative (SFARI) on the role of UBE3A and its connections to autism and Angelman syndrome.
Located in News
Ben Philpot receives funds from the Angelman Syndrome Foundation, NIH
Located in News
Philpot lab publishes cover story in the journal Neuron
October 2012 - A new activity-dependent role for the protein heavily implicated in autism, Neuroligin-1, identified
Located in News
The work of Mark Zylka, PhD, and Ben Philpot, PhD, is featured by Autism Speaks in its list of 10 major advances in autism research in 2013.
Located in News
Ben Philpot receives new R01 funding
Located in News
Philpot lab publication in the journal Neuron outlines how brain cell activity imbalance may account for seizure susceptibility in Angelman syndrome
New research by Philpot lab researchers may have pinpointed an underlying cause of the seizures that affect 90 percent of people with Angelman syndrome (AS), a neurodevelopmental disorder.
Located in News